Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Express Scripts
Dow
McKinsey
Julphar
Chubb
Fuji
Federal Trade Commission
Colorcon
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

BACTOCILL Drug Profile

« Back to Dashboard

Which patents cover Bactocill, and what generic alternatives are available?

Bactocill is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in six NDAs.

The generic ingredient in BACTOCILL is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
Drug patent expirations by year for BACTOCILL
Medical Subject Heading (MeSH) Categories for BACTOCILL

US Patents and Regulatory Information for BACTOCILL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline BACTOCILL oxacillin sodium CAPSULE;ORAL 061336-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium INJECTABLE;INJECTION 062736-001 Dec 19, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium CAPSULE;ORAL 062241-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium INJECTABLE;INJECTION 061334-009 Mar 26, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium INJECTABLE;INJECTION 061334-007 Mar 26, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare BACTOCILL IN PLASTIC CONTAINER oxacillin sodium INJECTABLE;INJECTION 050640-002 Oct 26, 1989 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium CAPSULE;ORAL 062241-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium CAPSULE;ORAL 061336-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium INJECTABLE;INJECTION 061334-006 Mar 26, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline BACTOCILL oxacillin sodium FOR SOLUTION;ORAL 062321-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Teva
Federal Trade Commission
Merck
Accenture
Cantor Fitzgerald
Colorcon
Farmers Insurance
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot